Previous close | 31.43 |
Open | 31.25 |
Bid | 33.18 x 1200 |
Ask | 34.60 x 800 |
Day's range | 30.50 - 34.13 |
52-week range | 4.41 - 36.68 |
Volume | |
Avg. volume | 962,729 |
Market cap | 1.199B |
Beta (5Y monthly) | -1.06 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.09 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 42.14 |
Key Insights The considerable ownership by individual investors in Biomea Fusion indicates that they collectively have...
A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.
Preliminary data from an ongoing mid-stage study shows that treatment with Biomea's (BMEA) lead candidate demonstrated a robust glucose-lowering response in patients with type II diabetes.
Pipelines updates from Viking Therapeutics (VKTX) and Intra-Cellular (ITCI) are the key highlights for the biotech sector.
Here is how Aspira (AWH) and Biomea Fusion, Inc. (BMEA) have performed compared to their sector so far this year.
Biomea Fusion, Inc. (BMEA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
What happened Shares of Biomea Fusion (NASDAQ: BMEA) were up 24.1% for the week as of Friday morning, according to data provided by S&P Global Market Intelligence. The biotech company's stock closed at $7.
Biomea Fusion (BMEA) announces the successful dosing of the first patient in phase I/Ib study of BMF-219 in KRAS mutant solid tumors. Stocks rise 11.69% in response.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
A look at the shareholders of Biomea Fusion, Inc. ( NASDAQ:BMEA ) can tell us which group is most powerful. With 41...
Insiders who purchased Biomea Fusion, Inc. ( NASDAQ:BMEA ) shares in the past 12 months are unlikely to be deeply...
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
The big shareholder groups in Biomea Fusion, Inc. ( NASDAQ:BMEA ) have power over the company. Generally speaking, as a...